Pfizer To Sell API Production Facility In Michigan

Southfield, MI - Binswanger announced recently that it has been named exclusive agent for the sale of Pfizer's fully operational, 512,000 sq. ft., high-volume API production plant in Holland, Michigan. The plant is located on a 46-acre campus and includes a separate research and development facility and pilot plant.

Pfizer's facility is FDA approved and has been a key site in developing and supplying the active ingredients for a number of major Pfizer products. Binswanger is pleased to bring this exceptional high capacity, low cost production site to the market.

Binswanger notes that the manufacturing campus is ideally situated -- Michigan is the #2 state in the nation for R&D investments, the fastest growing state for Life Science investment at over $2 billion per year, and is benefiting from a $27 million investment into Life Science development in the state's technology tri-corridor. Michigan also boasts a superior workforce. More than 35 percent of the population have attended college, while 5 percent hold graduate or professional degrees. It is perfectly suited to complement any pharmaceutical or biomedical manufacturer.

Binswanger is aggressively marketing this property to users in Research, Development, Pharmaceutical, Active Pharmaceutical Ingredient, Intermediates, Animal Science and Chemical Industries.

SOURCE: Binswanger